Distributed by

Marketer for

Distributed by

Marketer for

ROCHE THAILAND LTD

Featured products of Roche

Actemra/Actemra SC

Actemra inj 400 mg/20 mL

tocilizumab

Packing/Price

(vial) 1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Actemra inj 80 mg/4 mL

tocilizumab

Packing/Price

(vial) 1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Actemra SC inj 162 mg/0.9 mL

tocilizumab

Packing/Price

1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Alecensa

Alecensa hard cap 150 mg

alectinib

Packing/Price

224's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01ED03 - alectinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.

Avastin

Avastin conc for soln for infusion 100 mg/4 mL

bevacizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.

CellCept

CellCept cap 250 mg

mycophenolate mofetil

Packing/Price

100's

MIMS Class

Immunosuppressants

ATC Classification

L04AA06 - mycophenolic acid : Belongs to the class of selective immunosuppressive agents. Used to induce immunosuppression.

CellCept tab 500 mg

mycophenolate mofetil

Packing/Price

50's

MIMS Class

Immunosuppressants

ATC Classification

L04AA06 - mycophenolic acid : Belongs to the class of selective immunosuppressive agents. Used to induce immunosuppression.

Evrysdi

Evrysdi powd for oral soln 0.75 mg/mL

risdiplam

Packing/Price

1's

MIMS Class

Other Drugs Acting on Musculo-Skeletal System

ATC Classification

M09AX10 - risdiplam : Belongs to the class of other drugs for disorders of the musculo-skeletal system.

Gavreto

Gavreto hard cap 100 mg

pralsetinib

Packing/Price

60's90's120's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EX23 - pralsetinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.

Gazyva

Gazyva soln for infusion 1000 mg/40 mL

obinutuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FA03 - obinutuzumab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.

Hemlibra

Hemlibra soln for inj 30 mg/mL

emicizumab

Packing/Price

1's

MIMS Class

Haemostatics

ATC Classification

B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.

Herceptin/Herceptin SC

Herceptin powd for soln for infusion 150 mg

trastuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Herceptin powd for soln for infusion 440 mg

trastuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Herceptin SC inj 600 mg/5 mL

trastuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Kadcyla

Kadcyla powd for infusion 100 mg

trastuzumab emtansine

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD03 - trastuzumab emtansine : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Kadcyla powd for infusion 160 mg

trastuzumab emtansine

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD03 - trastuzumab emtansine : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

MabThera/MabThera SC

MabThera infusion 100 mg/10 mL

rituximab

Packing/Price

2 × 1's

MIMS Class

Targeted Cancer Therapy, Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

ATC Classification

L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.

MabThera infusion 500 mg/50 mL

rituximab

Packing/Price

(vial) 1's

MIMS Class

Targeted Cancer Therapy, Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

ATC Classification

L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.

Mabthera SC soln for inj 1400 mg/11.7 mL

rituximab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

ATC Classification

L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.

Madopar 250/Madopar HBS/Madopar Dispersible 125

Madopar 250 tab

benserazide hydrochloride, levodopa

Packing/Price

100's

MIMS Class

Antiparkinsonian Drugs

ATC Classification

N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.

Madopar Dispersible 125 tab

benserazide hydrochloride, levodopa

Packing/Price

100's

MIMS Class

Antiparkinsonian Drugs

ATC Classification

N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.

Madopar HBS CR cap

benserazide hydrochloride, levodopa

Packing/Price

100's

MIMS Class

Antiparkinsonian Drugs

ATC Classification

N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.

Mircera

Mircera soln for inj 100 mcg/0.3 mL

methoxy polyethylene glycol-epoetin beta

Packing/Price

1's

MIMS Class

Haematopoietic Agents

ATC Classification

B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Mircera soln for inj 120 mcg/0.3 mL

methoxy polyethylene glycol-epoetin beta

Packing/Price

1's

MIMS Class

Haematopoietic Agents

ATC Classification

B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Mircera soln for inj 150 mcg/0.3 mL

methoxy polyethylene glycol-epoetin beta

Packing/Price

1's

MIMS Class

Haematopoietic Agents

ATC Classification

B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Mircera soln for inj 50 mcg/0.3 mL

methoxy polyethylene glycol-epoetin beta

Packing/Price

1's

MIMS Class

Haematopoietic Agents

ATC Classification

B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Mircera soln for inj 75 mcg/0.3 mL

methoxy polyethylene glycol-epoetin beta

Packing/Price

1's

MIMS Class

Haematopoietic Agents

ATC Classification

B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Perjeta

Perjeta soln for infusion 420 mg/vial

pertuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD02 - pertuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Phesgo

Phesgo soln for inj 1,200 mg/600 mg

pertuzumab, trastuzumab

Packing/Price

15 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FY01 - pertuzumab and trastuzumab : Belongs to the class of combinations of monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Phesgo soln for inj 600 mg/600 mg

pertuzumab, trastuzumab

Packing/Price

10 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FY01 - pertuzumab and trastuzumab : Belongs to the class of combinations of monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Polivy

Polivy powd for infusion 140 mg

polatuzumab vedotin

Packing/Price

((single-dose)) 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX14 - polatuzumab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Polivy powd for infusion 30 mg

polatuzumab vedotin

Packing/Price

((single-dose)) 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX14 - polatuzumab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Recormon

Recormon pre-filled inj 10000 IU/0.6 mL

epoetin beta

Packing/Price

1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Recormon pre-filled inj 2000 IU/0.3 mL

epoetin beta

Packing/Price

6 × 1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Recormon pre-filled inj 3000 IU/0.3 mL

epoetin beta

Packing/Price

6 × 1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Recormon pre-filled inj 30000 IU/0.6 mL

epoetin beta

Packing/Price

1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Recormon pre-filled inj 5000 IU/0.3 mL

epoetin beta

Packing/Price

6 × 1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Rocephin

Rocephin IM powd for inj 1 g

ceftriaxone disodium

Packing/Price

1's

MIMS Class

Cephalosporins

ATC Classification

J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.

Rocephin IM powd for inj 500 mg

ceftriaxone disodium

Packing/Price

1's

MIMS Class

Cephalosporins

ATC Classification

J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.

Rocephin infusion 2 g

ceftriaxone disodium

Packing/Price

1's

MIMS Class

Cephalosporins

ATC Classification

J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.

Rocephin IV powd for inj 1 g

ceftriaxone disodium

Packing/Price

1's

MIMS Class

Cephalosporins

ATC Classification

J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.

Rocephin IV powd for inj 500 mg

ceftriaxone disodium

Packing/Price

1's

MIMS Class

Cephalosporins

ATC Classification

J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.

Rozlytrek

Rozlytrek hard cap 100 mg

entrectinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EX14 - entrectinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.

Rozlytrek hard cap 200 mg

entrectinib

Packing/Price

90's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EX14 - entrectinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.

Tecentriq

Tecentriq conc for soln for infusion 1,200 mg/20 mL

atezolizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF05 - atezolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Tecentriq conc for soln for infusion 840 mg/14 mL

atezolizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF05 - atezolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Vabysmo

Vabysmo soln for inj 120 mg/mL

faricimab

Packing/Price

((single-dose; w/ transfer filter needle)) 1's

MIMS Class

Other Eye Preparations

ATC Classification

S01LA09 - faricimab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.

Xofluza

Xofluza FC tab 20 mg

baloxavir marboxil

Packing/Price

2's

MIMS Class

Antivirals

ATC Classification

J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.

Xofluza FC tab 40 mg

baloxavir marboxil

Packing/Price

2's

MIMS Class

Antivirals

ATC Classification

J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.

Xofluza Granules for Oral Suspension

Xofluza Granules for Oral Suspension granules for oral susp 2 mg/mL

baloxavir marboxil

Packing/Price

50 mL x 1's

MIMS Class

Antivirals

ATC Classification

J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.

Distributed by DKSH

Actemra/Actemra SC

Actemra inj 400 mg/20 mL

tocilizumab

Packing/Price

(vial) 1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Actemra inj 80 mg/4 mL

tocilizumab

Packing/Price

(vial) 1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Actemra SC inj 162 mg/0.9 mL

tocilizumab

Packing/Price

1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Alecensa

Alecensa hard cap 150 mg

alectinib

Packing/Price

224's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01ED03 - alectinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.

Avastin

Avastin conc for soln for infusion 100 mg/4 mL

bevacizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.

CellCept

CellCept cap 250 mg

mycophenolate mofetil

Packing/Price

100's

MIMS Class

Immunosuppressants

ATC Classification

L04AA06 - mycophenolic acid : Belongs to the class of selective immunosuppressive agents. Used to induce immunosuppression.

CellCept tab 500 mg

mycophenolate mofetil

Packing/Price

50's

MIMS Class

Immunosuppressants

ATC Classification

L04AA06 - mycophenolic acid : Belongs to the class of selective immunosuppressive agents. Used to induce immunosuppression.

Evrysdi

Evrysdi powd for oral soln 0.75 mg/mL

risdiplam

Packing/Price

1's

MIMS Class

Other Drugs Acting on Musculo-Skeletal System

ATC Classification

M09AX10 - risdiplam : Belongs to the class of other drugs for disorders of the musculo-skeletal system.

Gavreto

Gavreto hard cap 100 mg

pralsetinib

Packing/Price

60's90's120's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EX23 - pralsetinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.

Gazyva

Gazyva soln for infusion 1000 mg/40 mL

obinutuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FA03 - obinutuzumab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.

Hemlibra

Hemlibra soln for inj 30 mg/mL

emicizumab

Packing/Price

1's

MIMS Class

Haemostatics

ATC Classification

B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.

Herceptin/Herceptin SC

Herceptin powd for soln for infusion 150 mg

trastuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Herceptin powd for soln for infusion 440 mg

trastuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Herceptin SC inj 600 mg/5 mL

trastuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Kadcyla

Kadcyla powd for infusion 100 mg

trastuzumab emtansine

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD03 - trastuzumab emtansine : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Kadcyla powd for infusion 160 mg

trastuzumab emtansine

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD03 - trastuzumab emtansine : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

MabThera/MabThera SC

MabThera infusion 100 mg/10 mL

rituximab

Packing/Price

2 × 1's

MIMS Class

Targeted Cancer Therapy, Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

ATC Classification

L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.

MabThera infusion 500 mg/50 mL

rituximab

Packing/Price

(vial) 1's

MIMS Class

Targeted Cancer Therapy, Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

ATC Classification

L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.

Mabthera SC soln for inj 1400 mg/11.7 mL

rituximab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

ATC Classification

L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.

Madopar 250/Madopar HBS/Madopar Dispersible 125

Madopar 250 tab

benserazide hydrochloride, levodopa

Packing/Price

100's

MIMS Class

Antiparkinsonian Drugs

ATC Classification

N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.

Madopar Dispersible 125 tab

benserazide hydrochloride, levodopa

Packing/Price

100's

MIMS Class

Antiparkinsonian Drugs

ATC Classification

N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.

Madopar HBS CR cap

benserazide hydrochloride, levodopa

Packing/Price

100's

MIMS Class

Antiparkinsonian Drugs

ATC Classification

N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.

Mircera

Mircera soln for inj 100 mcg/0.3 mL

methoxy polyethylene glycol-epoetin beta

Packing/Price

1's

MIMS Class

Haematopoietic Agents

ATC Classification

B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Mircera soln for inj 120 mcg/0.3 mL

methoxy polyethylene glycol-epoetin beta

Packing/Price

1's

MIMS Class

Haematopoietic Agents

ATC Classification

B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Mircera soln for inj 150 mcg/0.3 mL

methoxy polyethylene glycol-epoetin beta

Packing/Price

1's

MIMS Class

Haematopoietic Agents

ATC Classification

B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Mircera soln for inj 50 mcg/0.3 mL

methoxy polyethylene glycol-epoetin beta

Packing/Price

1's

MIMS Class

Haematopoietic Agents

ATC Classification

B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Mircera soln for inj 75 mcg/0.3 mL

methoxy polyethylene glycol-epoetin beta

Packing/Price

1's

MIMS Class

Haematopoietic Agents

ATC Classification

B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Perjeta

Perjeta soln for infusion 420 mg/vial

pertuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD02 - pertuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Phesgo

Phesgo soln for inj 1,200 mg/600 mg

pertuzumab, trastuzumab

Packing/Price

15 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FY01 - pertuzumab and trastuzumab : Belongs to the class of combinations of monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Phesgo soln for inj 600 mg/600 mg

pertuzumab, trastuzumab

Packing/Price

10 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FY01 - pertuzumab and trastuzumab : Belongs to the class of combinations of monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Polivy

Polivy powd for infusion 140 mg

polatuzumab vedotin

Packing/Price

((single-dose)) 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX14 - polatuzumab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Polivy powd for infusion 30 mg

polatuzumab vedotin

Packing/Price

((single-dose)) 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX14 - polatuzumab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Recormon

Recormon pre-filled inj 10000 IU/0.6 mL

epoetin beta

Packing/Price

1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Recormon pre-filled inj 2000 IU/0.3 mL

epoetin beta

Packing/Price

6 × 1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Recormon pre-filled inj 3000 IU/0.3 mL

epoetin beta

Packing/Price

6 × 1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Recormon pre-filled inj 30000 IU/0.6 mL

epoetin beta

Packing/Price

1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Recormon pre-filled inj 5000 IU/0.3 mL

epoetin beta

Packing/Price

6 × 1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.

Rocephin

Rocephin IM powd for inj 1 g

ceftriaxone disodium

Packing/Price

1's

MIMS Class

Cephalosporins

ATC Classification

J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.

Rocephin IM powd for inj 500 mg

ceftriaxone disodium

Packing/Price

1's

MIMS Class

Cephalosporins

ATC Classification

J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.

Rocephin infusion 2 g

ceftriaxone disodium

Packing/Price

1's

MIMS Class

Cephalosporins

ATC Classification

J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.

Rocephin IV powd for inj 1 g

ceftriaxone disodium

Packing/Price

1's

MIMS Class

Cephalosporins

ATC Classification

J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.

Rocephin IV powd for inj 500 mg

ceftriaxone disodium

Packing/Price

1's

MIMS Class

Cephalosporins

ATC Classification

J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.

Rozlytrek

Rozlytrek hard cap 100 mg

entrectinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EX14 - entrectinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.

Rozlytrek hard cap 200 mg

entrectinib

Packing/Price

90's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EX14 - entrectinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.

Tecentriq

Tecentriq conc for soln for infusion 1,200 mg/20 mL

atezolizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF05 - atezolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Tecentriq conc for soln for infusion 840 mg/14 mL

atezolizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF05 - atezolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Vabysmo

Vabysmo soln for inj 120 mg/mL

faricimab

Packing/Price

((single-dose; w/ transfer filter needle)) 1's

MIMS Class

Other Eye Preparations

ATC Classification

S01LA09 - faricimab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.

Xofluza

Xofluza FC tab 20 mg

baloxavir marboxil

Packing/Price

2's

MIMS Class

Antivirals

ATC Classification

J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.

Xofluza FC tab 40 mg

baloxavir marboxil

Packing/Price

2's

MIMS Class

Antivirals

ATC Classification

J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.

Xofluza Granules for Oral Suspension

Xofluza Granules for Oral Suspension granules for oral susp 2 mg/mL

baloxavir marboxil

Packing/Price

50 mL x 1's

MIMS Class

Antivirals

ATC Classification

J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.

Marketer for Chugai Pharma

Enspryng

Enspryng soln for inj 120 mg/mL

satralizumab

Packing/Price

1's

MIMS Class

Immunosuppressants

ATC Classification

L04AC19 - satralizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.